10.30.25 -- Advancing Cell & Gene Therapies: Inside Leading CDMO Innovations

Our mission is clear: to help sponsors reduce costs, shorten timelines, and mitigate development risks, enabling them to achieve critical milestones, secure investments, and advance therapies.

Consider partnering with a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance.

We’re pioneering how cell therapy's most productive explorations can benefit your team by uniting and improving every component – processes, scale-up, raw material supplies, analytics, and GMP.

For cell expansion to occur, we use the world-leading cell line: Pro10™ by AskBio. Viralgen is the only company in the world with a license to manufacture for third parties.

Our services include high-throughput drug substance production, state-of-the-art drug product manufacturing suites, analytical testing, and fill and finish.

Safety and efficacy in cell and gene therapy treatments necessitate rigorous quality control. See how an outsourcing partner can help deliver safe, efficacious therapies to patients.

Gain access to high-quality, lentiviral vectors that are optimized by design to meet the specific needs of clinical research and commercial-scale production.

Discover how our production platform, delivering rAAV8 at concentrations exceeding 2.0E15 GC/L, can upgrade your gene therapy pipeline with unparalleled yield, quality, and scalability.

With a track record of more than 7,500 GMP batches and proven platforms for multiple modalities, we deliver speed, scalability, and reliability to help bring cures to patients faster.